Payden & Rygel’s Clorox CLX Stock Holding History

Payden & Rygel’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-260	Closed	-$27K	–	131
2015 Q2	$27K	Hold	260	–	–	﹤0.01%	130
2015 Q1	$29K	Hold	260	–	–	﹤0.01%	136
2014 Q4	$27K	Hold	260	–	–	0.01%	136
2014 Q3	$25K	Hold	260	–	–	﹤0.01%	142
2014 Q2	$24K	Hold	260	–	–	0.01%	152
2014 Q1	$23K	Buy	260 +160	+160%	+$14K	0.01%	145
2013 Q4	$9K	Hold	100	–	–	﹤0.01%	190
2013 Q3	$8K	Hold	100	–	–	﹤0.01%	177
2013 Q2	$8K	Buy	+100	New	+$8.6K	﹤0.01%	172

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

CRC

Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Payden & Rygel's CLX Position: Q3 2015 in Review

Payden & Rygel sold out of Clorox (CLX) in Q3 2015, closing a stake of 260 shares — an estimated $27K sold.

Payden & Rygel first reported a position in CLX in Q2 2013 and held it in 9 quarters. The position peaked at $29K in Q1 2015. 778 funds tracked by Wall St. Rank hold CLX as of Q3 2015.

Payden & Rygel reported no remaining Clorox position as of Q3 2015 after selling out during the quarter.
Payden & Rygel sold 260 Clorox shares in Q3 2015, an estimated $27K.
Payden & Rygel first reported a position in Clorox in Q2 2013 and held it in 9 quarters.
Payden & Rygel's Clorox position peaked at $29K in Q1 2015.
778 funds tracked by Wall St. Rank held Clorox as of Q3 2015.

Based on Payden & Rygel's 13F filing for Q3 2015, filed 2 Nov 2015.